Yseop
5 known investors
Find your way into Yseop
90 people in our graph share verified history with the Yseop team — schools, employers, funds. One of them is your warm intro.
Bruno Crémelunlockedknows Emmanuel Walckenaer · together at CentraleSupélec (overlapped)
×2knows the team · via CentraleSupélec
×9knows the team · via Lycée Sainte-Geneviève
Yseop provides an AI-powered platform that automates medical writing and regulatory reporting tasks for life sciences teams, accelerating document submission timelines within the CTD pyramid framework. The platform uses neuro-symbolic AI to transform complex documentation workflows and ensure compliance in pharmaceutical regulatory processes.
Founders & leadership
EW
Emmanuel WalckenaerinCEOEmmanuel Walckenaer is CEO of Yseop, which provides an AI-powered platform for automating medical writing and regulatory reporting in the pharmaceutical industry. He has prior experience in healthcare, IoT, artificial intelligence, and wireless sectors, with expertise in sales, business strategy, and mergers and acquisitions.
Investors · 5
Also in the syndicate · 3
Eli LillyNextStage AMNovartis (dRx Capital)
Funding
SEC filings, press & company announcements- Undisclosed amountstrategic investment roundDec 2023
Eli Lilly, NextStage AM, Novartis (dRx Capital), Wille Finance
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Yseop do?
- Yseop provides an AI-powered platform that automates medical writing and regulatory reporting tasks for life sciences teams, accelerating document submission timelines within the CTD pyramid framework. The platform uses neuro-symbolic AI to transform complex documentation workflows and ensure compliance in pharmaceutical regulatory processes.
- Who are Yseop's investors?
- Yseop's investors include Claret Capital Partners, Wille Finance.